Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

genericon pharma gesellschaft m.b.h., hafnerstraße 211, graz, austrija - vildagliptin metforminklorid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 50 mg vildagliptina i 1000 mg metforminklorida (što odgovara 780 mg metformina).

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

genericon pharma gesellschaft m.b.h., hafnerstraße 211, graz, austrija - vildagliptin metforminklorid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 50 mg vildagliptina i 850 mg metforminklorida (što odgovara 663 mg metformina).

Europska Unija - hrvatski - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Europska Unija - hrvatski - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - sitagliptinklorid hidrat metforminklorid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina i 850 mg metforminklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as grindeks, krustpils iela 53, riga, latvija - sitagliptinklorid hidrat metforminklorid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina i 1000 mg metformina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

teva gmbh, graf-arco-str. 3, ulm, njemačka - sitagliptinklorid hidrat metforminklorid - filmom obložena tableta - urbroj: svaka tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

teva gmbh, graf-arco-str. 3, ulm, njemačka - sitagliptinklorid hidrat metforminklorid - filmom obložena tableta - urbroj: svaka tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 850 mg metforminklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - sitagliptinklorid hidrat metforminklorid - tableta s prilagođenim oslobađanjem - urbroj: svaka tableta sadrži 100 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - sitagliptinklorid hidrat metforminklorid - tableta s prilagođenim oslobađanjem - urbroj: svaka tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida